Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Enzalutamide Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors.

Udhane V, Maranto C, Hoang DT, Gu L, Erickson A, Devi S, Talati PG, Banerjee A, Iczkowski KA, Jacobsohn K, See WA, Mirtti T, Kilari D, Nevalainen MT.

Mol Cancer Ther. 2019 Sep 23. pii: molcanther.0508.2019. doi: 10.1158/1535-7163.MCT-19-0508. [Epub ahead of print]

PMID:
31548294
2.

Eosinophilic Kidney Tumors: Old and New.

Iczkowski KA, Czaja RC.

Arch Pathol Lab Med. 2019 Aug 12. doi: 10.5858/arpa.2019-0203-RA. [Epub ahead of print]

PMID:
31403331
3.

KIF3B protein expression loss correlates with metastatic ability of prostate cancer.

Kravtsov O, Hartley CP, Compérat EM, Iczkowski KA.

Am J Clin Exp Urol. 2019 Jun 15;7(3):178-181. eCollection 2019.

4.

Improving sensitivity of amyloid detection by Congo red stain by using polarizing microscope and avoiding pitfalls.

El-Meanawy A, Mueller C, Iczkowski KA.

Diagn Pathol. 2019 Jun 14;14(1):57. doi: 10.1186/s13000-019-0822-4.

5.

MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia.

Magers MJ, Iczkowski KA, Montironi R, Grignon DJ, Zhang S, Williamson SR, Yang X, Wang M, Osunkoya AO, Lopez-Beltran A, Hes O, Eble JN, Cheng L.

Mod Pathol. 2019 Nov;32(11):1666-1674. doi: 10.1038/s41379-019-0297-6. Epub 2019 Jun 12.

PMID:
31189999
6.

Gleason Probability Maps: A Radiomics Tool for Mapping Prostate Cancer Likelihood in MRI Space.

McGarry SD, Bukowy JD, Iczkowski KA, Unteriner JG, Duvnjak P, Lowman AK, Jacobsohn K, Hohenwalter M, Griffin MO, Barrington AW, Foss HE, Keuter T, Hurrell SL, See WA, Nevalainen MT, Banerjee A, LaViolette PS.

Tomography. 2019 Mar;5(1):127-134. doi: 10.18383/j.tom.2018.00033.

7.

Rete Testis Invasion Is Consistent With Pathologic Stage T1 in Germ Cell Tumors.

Farooq A, Jorda M, Whittington E, Kryvenko ON, Braunhut BL, Pavan N, Procházková K, Zhang L, Rai S, Miller T, Liu J, Szabo A, Iczkowski KA.

Am J Clin Pathol. 2019 Apr 2;151(5):479-485. doi: 10.1093/ajcp/aqy168.

PMID:
30576407
8.

Large-Gland Proliferations of the Prostate.

Iczkowski KA.

Surg Pathol Clin. 2018 Dec;11(4):687-712. doi: 10.1016/j.path.2018.07.001. Epub 2018 Oct 17. Review.

PMID:
30447836
9.

Automatic grading of prostate cancer in digitized histopathology images: Learning from multiple experts.

Nir G, Hor S, Karimi D, Fazli L, Skinnider BF, Tavassoli P, Turbin D, Villamil CF, Wang G, Wilson RS, Iczkowski KA, Lucia MS, Black PC, Abolmaesumi P, Goldenberg SL, Salcudean SE.

Med Image Anal. 2018 Dec;50:167-180. doi: 10.1016/j.media.2018.09.005. Epub 2018 Sep 24.

PMID:
30340027
10.

Primary angiosarcoma of the testis with retroperitoneal metastasis.

Piotrowski JT, Schaefer MB, Charlson JA, Iczkowski KA, Johnson SC.

Urol Case Rep. 2018 Sep 19;21:116-118. doi: 10.1016/j.eucr.2018.09.014. eCollection 2018 Nov. No abstract available.

11.

Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer.

McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD, See WA, LaViolette PS.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1179-1187. doi: 10.1016/j.ijrobp.2018.04.044. Epub 2018 Apr 24.

12.

Variation in nuclear size and PD-L2 positivity correlate with aggressive chromophobe renal cell carcinoma.

Mostafa ME, Abdelkader A, Kuroda N, Pérez-Montiel D, Banerjee A, Hes O, Iczkowski KA.

Ann Diagn Pathol. 2018 Jun;34:31-35. doi: 10.1016/j.anndiagpath.2018.01.002. Epub 2018 Jan 10.

PMID:
29661724
13.

Investigation of Physical Phenomena Underlying Temporal-Enhanced Ultrasound as a New Diagnostic Imaging Technique: Theory and Simulations.

Bayat S, Azizi S, Daoud MI, Nir G, Imani F, Gerardo CD, Yan P, Tahmasebi A, Vignon F, Sojoudi S, Wilson S, Iczkowski KA, Lucia MS, Goldenberg L, Salcudean SE, Abolmaesumi P, Mousavi P.

IEEE Trans Ultrason Ferroelectr Freq Control. 2018 Mar;65(3):400-410. doi: 10.1109/TUFFC.2017.2785230.

PMID:
29505407
14.

STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair.

Maranto C, Udhane V, Hoang DT, Gu L, Alexeev V, Malas K, Cardenas K, Brody JR, Rodeck U, Bergom C, Iczkowski KA, Jacobsohn K, See W, Schmitt SM, Nevalainen MT.

Clin Cancer Res. 2018 Apr 15;24(8):1917-1931. doi: 10.1158/1078-0432.CCR-17-2768. Epub 2018 Feb 26.

15.

Utility of Pathology Imagebase for standardisation of prostate cancer grading.

Egevad L, Delahunt B, Berney DM, Bostwick DG, Cheville J, Comperat E, Evans AJ, Fine SW, Grignon DJ, Humphrey PA, Hörnblad J, Iczkowski KA, Kench JG, Kristiansen G, Leite KRM, Magi-Galluzzi C, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, True LD, Tsuzuki T, van der Kwast T, Varma M, Zhou M, Clements M.

Histopathology. 2018 Jul;73(1):8-18. doi: 10.1111/his.13471. Epub 2018 Mar 5.

PMID:
29359484
16.

Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging.

Hurrell SL, McGarry SD, Kaczmarowski A, Iczkowski KA, Jacobsohn K, Hohenwalter MD, Hall WA, See WA, Banerjee A, Charles DK, Nevalainen MT, Mackinnon AC, LaViolette PS.

J Med Imaging (Bellingham). 2018 Jan;5(1):011004. doi: 10.1117/1.JMI.5.1.011004. Epub 2017 Oct 27.

17.

The New Realization About Cribriform Prostate Cancer.

Iczkowski KA, Paner GP, Van der Kwast T.

Adv Anat Pathol. 2018 Jan;25(1):31-37. doi: 10.1097/PAP.0000000000000168. Review.

PMID:
28820750
18.

Metastatic sarcomatoid renal cell carcinoma manifesting as a subcutaneous soft tissue mass.

Logunova V, Sokumbi O, Iczkowski KA.

J Cutan Pathol. 2017 Oct;44(10):874-877. doi: 10.1111/cup.12998. Epub 2017 Jul 24.

PMID:
28675457
19.

Tissue-Specific MicroRNA Expression Patterns in Four Types of Kidney Disease.

Baker MA, Davis SJ, Liu P, Pan X, Williams AM, Iczkowski KA, Gallagher ST, Bishop K, Regner KR, Liu Y, Liang M.

J Am Soc Nephrol. 2017 Oct;28(10):2985-2992. doi: 10.1681/ASN.2016121280. Epub 2017 Jun 29.

20.

Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm.

Raychaudhuri R, Riese MJ, Bylow K, Burfeind J, Mackinnon AC, Tolat PP, Iczkowski KA, Kilari D.

Clin Genitourin Cancer. 2017 Oct;15(5):e897-e901. doi: 10.1016/j.clgc.2017.05.018. Epub 2017 May 25. No abstract available.

PMID:
28645484
21.

Detection and grading of prostate cancer using temporal enhanced ultrasound: combining deep neural networks and tissue mimicking simulations.

Azizi S, Bayat S, Yan P, Tahmasebi A, Nir G, Kwak JT, Xu S, Wilson S, Iczkowski KA, Lucia MS, Goldenberg L, Salcudean SE, Pinto PA, Wood B, Abolmaesumi P, Mousavi P.

Int J Comput Assist Radiol Surg. 2017 Aug;12(8):1293-1305. doi: 10.1007/s11548-017-1627-0. Epub 2017 Jun 20.

PMID:
28634789
22.

PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform.

Ronen S, Abbott DW, Kravtsov O, Abdelkader A, Xu Y, Banerjee A, Iczkowski KA.

Hum Pathol. 2017 Jul;65:85-91. doi: 10.1016/j.humpath.2017.04.024. Epub 2017 May 10.

PMID:
28504208
24.

Genomic Pathology and Cancer Biomarkers: Prostate Cancer.

Iczkowski KA.

Crit Rev Oncog. 2017;22(5-6):515-525. doi: 10.1615/CritRevOncog.2017020539. Review.

PMID:
29604929
25.

Analysis of Zinc-Exporters Expression in Prostate Cancer.

Singh CK, Malas KM, Tydrick C, Siddiqui IA, Iczkowski KA, Ahmad N.

Sci Rep. 2016 Nov 11;6:36772. doi: 10.1038/srep36772.

26.

Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.

Hoang DT, Iczkowski KA, Kilari D, See W, Nevalainen MT.

Oncotarget. 2017 Jan 10;8(2):3724-3745. doi: 10.18632/oncotarget.12554. Review.

27.

Editorial Comment.

Iczkowski KA.

J Urol. 2017 Jan;197(1):82. doi: 10.1016/j.juro.2016.07.103. Epub 2016 Oct 4. No abstract available.

PMID:
27717689
28.

Outcome of Gleason 3 + 5 = 8 Prostate Cancer Diagnosed on Needle Biopsy: Prognostic Comparison with Gleason 4 + 4 = 8.

Harding-Jackson N, Kryvenko ON, Whittington EE, Eastwood DC, Tjionas GA, Jorda M, Iczkowski KA.

J Urol. 2016 Oct;196(4):1076-81. doi: 10.1016/j.juro.2016.05.105. Epub 2016 Jun 2.

PMID:
27265220
29.

Calcitonin Receptor-Zonula Occludens-1 Interaction Is Critical for Calcitonin-Stimulated Prostate Cancer Metastasis.

Aljameeli A, Thakkar A, Thomas S, Lakshmikanthan V, Iczkowski KA, Shah GV.

PLoS One. 2016 Mar 2;11(3):e0150090. doi: 10.1371/journal.pone.0150090. eCollection 2016.

30.

Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients.

Kilari D, Iczkowski KA, Pandya C, Robin AJ, Messing EM, Guancial E, Kim ES.

Anticancer Res. 2016 Feb;36(2):495-501.

PMID:
26851002
31.

Evidence for a Proapoptotic Role of Matrix Metalloproteinase-26 in Human Prostate Cancer Cells and Tissues.

Khamis ZI, Iczkowski KA, Man YG, Bou-Dargham MJ, Sang QX.

J Cancer. 2016 Jan 1;7(1):80-7. doi: 10.7150/jca.13067. eCollection 2016.

32.

Immunohistochemical distinction of metastases of renal cell carcinoma to the adrenal from primary adrenal nodules, including oncocytic tumor.

Li H, Hes O, MacLennan GT, Eastwood DC, Iczkowski KA.

Virchows Arch. 2015 May;466(5):581-8. doi: 10.1007/s00428-015-1732-9. Epub 2015 Feb 19.

PMID:
25690138
33.

Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate.

Lambert JR, Whitson RJ, Iczkowski KA, La Rosa FG, Smith ML, Wilson RS, Smith EE, Torkko KC, Gari HH, Lucia MS.

Prostate. 2015 Feb 15;75(3):255-65. doi: 10.1002/pros.22911. Epub 2014 Oct 18.

34.

Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.

Iczkowski KA, Egevad L, Ma J, Harding-Jackson N, Algaba F, Billis A, Camparo P, Cheng L, Clouston D, Comperat EM, Datta MW, Evans AG, Griffiths DF, Guo CC, Hailemariam S, Huang W, Humphrey PA, Jiang Z, Kahane H, Kristiansen G, La Rosa FG, Lopez-Beltran A, MacLennan GT, Magi-Galluzzi C, Merrimen J, Montironi R, Osunkoya AO, Picken MM, Rao N, Shah RB, Shanks JH, Shen SS, Tawfik OW, True LD, Van der Kwast T, Varma M, Wheeler TM, Zynger DL, Sahr N, Bostwick DG.

Ann Diagn Pathol. 2014 Dec;18(6):333-42. doi: 10.1016/j.anndiagpath.2014.08.010. Epub 2014 Sep 3.

PMID:
25263387
35.

Prostate pointers and pitfalls: the 10 most prevalent problems in prostate biopsy interpretation.

Iczkowski KA.

Ann Diagn Pathol. 2014 Oct;18(5):301-11. doi: 10.1016/j.anndiagpath.2014.07.003. Epub 2014 Jul 30. Review.

PMID:
25128443
36.

Paneth cell-like change in benign prostate can account for P504S (AMACR) reactivity.

Iczkowski KA.

Int J Clin Exp Pathol. 2014 May 15;7(6):3454-5. eCollection 2014.

37.

Gleason 6 cancer is still cancer.

Iczkowski KA, La Rosa FG.

Oncology (Williston Park). 2014 Jan;28(1):22, 24, 29. No abstract available.

38.

Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis.

Villarreal-Calderon R, Luévano-González A, Aragón-Flores M, Zhu H, Yuan Y, Xiang Q, Yan B, Stoll KA, Cross JV, Iczkowski KA, Mackinnon AC Jr.

Ann Diagn Pathol. 2014 Jun;18(3):129-35. doi: 10.1016/j.anndiagpath.2014.02.003. Epub 2014 Feb 11.

39.

A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors.

Dancik GM, Owens CR, Iczkowski KA, Theodorescu D.

Stem Cells. 2014 Apr;32(4):974-82. doi: 10.1002/stem.1625.

40.

Prostatic atrophy: its spatial proximity to carcinoma and intraepithelial neoplasia based on annotation of digital slides.

Iczkowski KA, Torkko KC, Wilson RS, Lucia MS, Bostwick DG.

Hum Pathol. 2014 Jan;45(1):54-8. doi: 10.1016/j.humpath.2013.07.041. Epub 2013 Oct 21.

PMID:
24157066
41.

Renal epithelioid angiomyolipoma with a negative premelanosome marker immunoprofile: a case report and review of the literature.

Hohensee SE, La Rosa FG, Homer P, Suby-Long T, Wilson S, Lucia SM, Iczkowski KA.

J Med Case Rep. 2013 Apr 29;7:118. doi: 10.1186/1752-1947-7-118.

42.

A competitive infection model of hematogenously disseminated candidiasis in mice redefines the role of Candida albicans IRS4 in pathogenesis.

Raman SB, Nguyen MH, Cheng S, Badrane H, Iczkowski KA, Wegener M, Gaffen SL, Mitchell AP, Clancy CJ.

Infect Immun. 2013 May;81(5):1430-8. doi: 10.1128/IAI.00743-12. Epub 2013 Feb 19.

43.

Renal cell carcinoma with clear cells, smooth muscle stroma, and negative for 3p deletion: a variant of renal angiomyoadenomatous tumour? A case report.

Iczkowski KA, Shanks JH, Burdge AH, Cheng L.

Histopathology. 2013 Feb;62(3):522-4. doi: 10.1111/his.12040. No abstract available.

PMID:
23339367
44.

Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents.

Khamis ZI, Iczkowski KA, Sang QX.

Med Res Rev. 2012 Sep;32(5):1026-77. doi: 10.1002/med.20232. Epub 2011 Jan 16. Review.

PMID:
22886631
45.

Pseudolumen size and perimeter in prostate cancer: correlation with patient outcome.

Iczkowski KA, Torkko KC, Kotnis GR, Wilson RS, Huang W, Wheeler TM, Abeyta AM, Lucia MS.

Prostate Cancer. 2011;2011:693853. doi: 10.1155/2011/693853. Epub 2011 Jul 14.

46.

Frequency of positive surgical margin at prostatectomy and its effect on patient outcome.

Iczkowski KA, Lucia MS.

Prostate Cancer. 2011;2011:673021. doi: 10.1155/2011/673021. Epub 2011 Jun 9.

47.

Pathology update for urologists.

Iczkowski KA, Montironi R, Cao D, Magi-Galluzzi C, Lucia MS.

Prostate Cancer. 2011;2011:183761. doi: 10.1155/2011/183761. Epub 2011 Sep 25. No abstract available.

48.

Papillary cystadenofibroma of epididymis: a case report.

Iczkowski KA, Pantazis CG.

Int J Clin Exp Pathol. 2011 Aug 15;4(6):629-31. Epub 2011 Aug 10.

49.

Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome.

Iczkowski KA, Torkko KC, Kotnis GR, Wilson RS, Huang W, Wheeler TM, Abeyta AM, La Rosa FG, Cook S, Werahera PN, Lucia MS.

Am J Clin Pathol. 2011 Jul;136(1):98-107. doi: 10.1309/AJCPZ7WBU9YXSJPE.

50.

Is atypical adenomatous hyperplasia of the prostate a precursor lesion?

Zhang C, Montironi R, MacLennan GT, Lopez-Beltran A, Li Y, Tan PH, Wang M, Zhang S, Iczkowski KA, Cheng L.

Prostate. 2011 Dec;71(16):1746-51. doi: 10.1002/pros.21391. Epub 2011 Apr 7.

PMID:
21480308

Supplemental Content

Loading ...
Support Center